Literature DB >> 22778834

The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing.

Craig W Lindsley.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 22778834      PMCID： PMC3368663          DOI： 10.1021/cn1000556

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN： 1948-7193            Impact factor:   4.418


× No keyword cloud information.
  6 in total

1.  Olanzapine (Zyprexa):characteristics of a new antipsychotic.

Authors:  C A Tamminga; J M Kane
Journal:  Expert Opin Investig Drugs       Date:  1997-11       Impact factor: 6.206

2.  The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.

Authors:  Fenghua Chen; Mads Breum Larsen; Connie Sánchez; Ove Wiborg
Journal:  Eur Neuropsychopharmacol       Date:  2005-03       Impact factor: 4.600

3.  Analgesic efficacy of controlled-release oxycodone in postoperative pain.

Authors:  A Sunshine; N Z Olson; A Colon; J Rivera; R F Kaiko; R D Fitzmartin; R F Reder; P D Goldenheim
Journal:  J Clin Pharmacol       Date:  1996-07       Impact factor: 3.126

4.  Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

Authors:  David A Shapiro; Sean Renock; Elaine Arrington; Louis A Chiodo; Li-Xin Liu; David R Sibley; Bryan L Roth; Richard Mailman
Journal:  Neuropsychopharmacology       Date:  2003-05-21       Impact factor: 7.853

5.  LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug.

Authors:  D T Wong; D W Robertson; F P Bymaster; J H Krushinski; L R Reid
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

6.  2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity.

Authors:  J P Yardley; G E Husbands; G Stack; J Butch; J Bicksler; J A Moyer; E A Muth; T Andree; H Fletcher; M N James
Journal:  J Med Chem       Date:  1990-10       Impact factor: 7.446
  6 in total
  7 in total

1.  The top prescription drugs of 2010 in the United States: antipsychotics show strong growth.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2011-06-15       Impact factor: 4.418

2.  (S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD).

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2010-08-18       Impact factor: 4.418

3.  2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-08-21       Impact factor: 4.418

4.  The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2013-06-19       Impact factor: 4.418

5.  The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2012-08-15       Impact factor: 4.418

6.  2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.

Authors:  Craig W Lindsley
Journal:  ACS Chem Neurosci       Date:  2014-04-16       Impact factor: 4.418

Review 7.  Regulation of HMG-CoA reductase in mammals and yeast.

Authors:  John S Burg; Peter J Espenshade
Journal:  Prog Lipid Res       Date:  2011-07-23       Impact factor: 16.195
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.